
Four simple lifestyle changes reduce cognitive decline and dementia risk
The probability of any American having dementia in their lifetime may be far greater than previously thought. For instance, a 2025 study that tracked a large sample of American adults across more than three decades found that their average likelihood of developing dementia between ages 55 to 95 was 42 per cent, and that figure was even higher among women, Black adults and those with genetic risk.
Now, a great deal of attention is being paid to how to stave off cognitive decline in the ageing American population. But what is often missing from this conversation is the role that chronic stress can play in how well people age from a cognitive standpoint, as well as everybody's risk for dementia.
We are professors at Penn State in the Center for Healthy Aging, with expertise in health psychology and neuropsychology.
Recent research shows that Americans who are currently middle-aged or older report experiencing more frequent stressful events than previous generations. A key driver behind this increase appears to be rising economic and job insecurity, especially in the wake of the 2007-2009 Great Recession and ongoing shifts in the labour market. Many people stay in the workforce longer due to financial necessity, as Americans are living longer and face greater challenges covering basic expenses in later life.
Therefore, it may be more important than ever to understand the pathways by which stress influences cognitive ageing.
Social isolation and stress
Although everyone experiences some stress in daily life, some people experience stress that is more intense, persistent or prolonged. It is this relatively chronic stress that is most consistently linked with poorer health.
In a recent review paper, our team summarised how chronic stress is a hidden but powerful factor underlying cognitive ageing, or the speed at which your cognitive performance slows down with age.
It is hard to overstate the impact of stress on your cognitive health as you age. This is in part because your psychological, behavioural and biological responses to everyday stressful events are closely intertwined, and each can amplify and interact with the other.
For instance, living alone can be stressful - particularly for older adults - and being isolated makes it more difficult to live a healthy lifestyle, as well as to detect and get help for signs of cognitive decline.
Moreover, stressful experiences - and your reactions to them - can make it harder to sleep well and to engage in other healthy behaviours, like getting enough exercise and maintaining a healthy diet.
In turn, insufficient sleep and a lack of physical activity can make it harder to cope with stressful experiences.
Stress is often missing from dementia prevention efforts
A robust body of research highlights the importance of at least 14 different factors that relate to your risk of Alzheimer's disease, a common and devastating form of dementia and other forms of dementia.
Although some of these factors may be outside of your control, such as diabetes or depression, many of these factors involve things that people do, such as physical activity, healthy eating and social engagement.
What is less well-recognised is that chronic stress is intimately interwoven with all of these factors that relate to dementia risk. Our work and research by others that we reviewed in our recent paper demonstrate that chronic stress can affect brain function and physiology, influence mood and make it harder to maintain healthy habits. Yet, dementia prevention efforts rarely address stress.
Avoiding stressful events and difficult life circumstances is typically not an option.
Where and how you live and work play a major role in how much stress you experience. For example, people with lower incomes, less education or those living in disadvantaged neighbourhoods often face more frequent stress and have fewer forms of support, such as nearby clinics, access to healthy food, reliable transportation or safe places to exercise or socialise - to help them manage the challenges of ageing. As shown in recent work on brain health in rural and underserved communities, these conditions can shape whether people have the chance to stay healthy as they age.
Over time, the effects of stress tend to build up, wearing down the body's systems and shaping long-term emotional and social habits.
Lifestyle changes to manage stress and lessen dementia risk
The good news is that there are multiple things that can be done to slow or prevent dementia, and our review suggests that these can be enhanced if the role of stress is better understood.
Whether you are a young, midlife or an older adult, it is not too early or too late to address the implications of stress on brain health and ageing. Here are a few ways you can take direct actions to help manage your level of stress:
· Follow lifestyle behaviours that can improve healthy ageing. These include: following a healthy diet, engaging in physical activity and getting enough sleep. Even small changes in these domains can make a big difference.
· Prioritise your mental health and well-being to the extent you can. Things as simple as talking about your worries, asking for support from friends and family and going outside regularly can be immensely valuable.
· If your doctor says that you or someone you care about should follow a new health care regimen, or suggests there are signs of cognitive impairment, ask them what support or advice they have for managing related stress.
· If you or a loved one feels socially isolated, consider how small shifts could make a difference. For instance, research suggests that adding just one extra interaction a day - even if it's a text message or a brief phone call - can be helpful, and that even interactions with people you don't know well, such as at a coffee shop or doctor's office, can have meaningful benefits.
Walkable neighbourhoods, lifelong learning
A 2025 study identified stress as one of 17 overlapping factors that affect the odds of developing any brain disease, including stroke, late-life depression and dementia. This work suggests that addressing stress and overlapping issues, such as loneliness, may have additional health benefits as well.
However, not all individuals or families are able to make big changes on their own. Research suggests that community-level and workplace interventions can reduce the risk of dementia. For example, safe and walkable neighbourhoods and opportunities for social connection and lifelong learning - such as through community classes and events - have the potential to reduce stress and promote brain health.
Importantly, researchers have estimated that even a modest delay in the disease onset of Alzheimer's would save hundreds of thousands of dollars for every American affected. Thus, providing incentives to companies that offer stress management resources could ultimately save money as well as help people age more healthfully.
In addition, stress related to the stigma around mental health and ageing can discourage people from seeking support that would benefit them. Even just thinking about your risk of dementia can be stressful in itself. Things can be done about this, too. For instance, normalising the use of hearing aids and integrating reports of perceived memory and mental health issues into routine primary care and workplace wellness programs could encourage people to engage with preventive services earlier.
Although research on potential biomedical treatments is ongoing and important, there is currently no cure for Alzheimer's disease. However, if interventions aimed at reducing stress were prioritised in guidelines for dementia prevention, the benefits could be far-reaching, resulting in both delayed disease onset and improved quality of life for millions of people.
Jennifer E. Graham-Engeland is a Professor of Biobehavioral Health at Penn State. Martin J. Sliwinski is a Professor of Human Development and Family Studies at Penn State.
The Independent
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Gulf Today
2 days ago
- Gulf Today
Many older people are really eager to be vaccinated
Paula Span, Tribune News Service Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out-of-pocket. Her doctor and several pharmacies turned her down because she was below the recommended age at the time, which was 60. So, in 2016, she celebrated her 60th birthday at her local CVS. 'I was there when they opened,' Beckham recalled. After getting her Zostavax shot, she said, 'I felt really relieved.' She has since received the newer, more effective shingles vaccine, as well as a pneumonia shot, an RSV vaccine to guard against respiratory syncytial virus, annual flu shots and all recommended COVID-19 vaccinations. Some older people are really eager to be vaccinated. Robin Wolaner, 71, a retired publisher in Sausalito, California, has been known to badger friends who delay getting recommended shots, sending them relevant medical studies. 'I'm sort of hectoring,' she acknowledged. Deana Hendrickson, 66, who provides daily care for three young grandsons in Los Angeles, sought an additional MMR shot, though she was vaccinated against measles, mumps, and rubella as a child, in case her immunity to measles had waned. For older adults who express more confidence in vaccine safety than younger groups, the past few months have brought welcome research. Studies have found important benefits from a newer vaccine and enhanced versions of older ones, and one vaccine may confer a major bonus that nobody foresaw. The new studies are coming at a fraught political moment. The nation's health secretary, Robert F. Kennedy Jr., has long disparaged certain vaccines, calling them unsafe and saying that the government officials who regulate them are compromised and corrupt. On June 9, Kennedy fired a panel of scientific advisers to the Centers for Disease Control and Prevention, and later replaced them with some who have been skeptical of vaccines. But so far, Kennedy has not tried to curb access to the shots for older Americans. The evidence that vaccines are beneficial remains overwhelming. The phrase 'Vaccines are not just for kids anymore' has become a favorite for William Schaffner, an infectious diseases specialist at Vanderbilt University Medical Center. 'The population over 65, which often suffers the worst impact of respiratory viruses and others, now has the benefit of vaccines that can prevent much of that serious illness,' he said. Take influenza, which annually sends from 140,000 to 710,000 people to hospitals, most of them seniors, and is fatal to 10% of hospitalized older adults. For about 15 years, the CDC has approved several enhanced flu vaccines for people 65 and older. More effective than the standard formulation, they either contain higher levels of the antigen that builds protection against the virus or incorporate an adjuvant that creates a stronger immune response. Or they're recombinant vaccines, developed through a different method, with higher antigen levels. In a meta-analysis in the Journal of the American Geriatrics Society, 'all the enhanced vaccine products were superior to the standard dose for preventing hospitalisations,' said Rebecca Morgan, a health research methodologist at Case Western Reserve University and an author of the study. Compared with the standard flu shot, the enhanced vaccines reduced the risk of hospitalization from the flu in older adults, by at least 11% and up to 18%. The CDC advises adults 65 and older to receive the enhanced vaccines, as many already do. More good news: Vaccines to prevent respiratory syncytial virus in people 60 and older are performing admirably. RSV is the most common cause of hospitalization for infants, and it also poses significant risks to older people. 'Season in and season out,' Schaffner said, 'it produces outbreaks of serious respiratory illness that rivals influenza.' Because the FDA first approved an RSV vaccine in 2023, the 2023-24 season provided 'the first opportunity to see it in a real-world context,' said Pauline Terebuh, an epidemiologist at Case Western Reserve School of Medicine and an author of a recent study in the journal JAMA Network Open. In analysing electronic health records for almost 800,000 patients, the researchers found the vaccines to be 75% effective against acute infection, meaning illness that was serious enough to send a patient to a health care provider. The vaccines were 75% effective in preventing emergency room or urgent care visits, and 75% effective against hospitalisation, both among those ages 60 to 74 and those older. Immunocompromised patients, despite having a somewhat lower level of protection from the vaccine, will also benefit from it, Terebuh said. As for adverse effects, the study found a very low risk for Guillain-Barré syndrome, a rare condition that causes muscle weakness and that typically follows an infection, in about 11 cases per 1 million doses of vaccine. That, she said, 'shouldn't dissuade people.' The CDC now recommends RSV vaccination for people 75 and older, and for those 60 to 74 if they're at higher risk of severe illness (from, say, heart disease). As data from the 2024-25 season becomes available, researchers hope to determine whether the vaccine will remain a one-and-done, or whether immunity will require repeated vaccination. People 65 and up express the greatest confidence in vaccine safety of any adult group, a KFF survey found in April. More than 80% said they were 'very 'or 'somewhat confident' about MMR, shingles, pneumonia, and flu shots. Although the COVID vaccine drew lower support among all adults, more than two-thirds of older adults expressed confidence in its safety. Even skeptics might become excited about one possible benefit of the shingles vaccine: This spring, Stanford researchers reported that over seven years, vaccination against shingles reduced the risk of dementia by 20%, a finding that made headlines. Biases often undermine observational studies that compare vaccinated with unvaccinated groups. 'People who are healthier and more health-motivated are the ones who get vaccinated,' said Pascal Geldsetzer, an epidemiologist at the Knight Initiative for Brain Resilience at Stanford and lead author of the study. 'It's hard to know whether this is cause and effect,' he said, 'or whether they're less likely to develop dementia anyway.' So the Stanford team took advantage of a 'natural experiment' when the first shingles vaccine, Zostavax, was introduced in Wales. Health officials set a strict age cutoff: People who turned 80 on or before Sept. 1, 2013, weren't eligible for vaccination, but those even slightly younger were eligible. In the sample of nearly 300,000 adults whose birthdays fell close to either side of that date, almost half of the eligible group received the vaccine, but virtually nobody in the older group did. 'Just as in a randomized trial, these comparison groups should be similar in every way,' Geldsetzer explained. A substantial reduction in dementia diagnoses in the vaccine-eligible group, with a much stronger protective effect in women, therefore constitutes 'more powerful and convincing evidence,' he said. The team also found reduced rates of dementia after shingles vaccines were introduced in Australia and other countries. 'We keep seeing this in one dataset after another,' Geldsetzer said. In the United States, where a more potent vaccine, Shingrix, became available in 2017 and supplanted Zostavax, Oxford investigators found an even stronger effect.


Middle East Eye
2 days ago
- Middle East Eye
Opioid pills discovered in US-backed food aid, Gaza authorities say
The Gaza government media office on Friday condemned the discovery of oxycodone pills reportedly discovered in flour bags distributed by 'American-Israeli' aid centres. 'We have so far documented four testimonies from citizens who found these pills inside the flour bags,' it said in a statement, warning of the 'possibility that some of these narcotic substances were deliberately ground or dissolved in the flour itself'. Oxycodone is an opioid meant to treat severe and long-term pain, often prescribed to cancer patients. The drug is highly addictive and can have life-threatening effects, including breathing complications and hallucinations. The media office's statement comes after several social media posts shared images of pills purportedly discovered in flour bags in Gaza. New MEE newsletter: Jerusalem Dispatch Sign up to get the latest insights and analysis on Israel-Palestine, alongside Turkey Unpacked and other MEE newsletters Palestinian pharmacist Omar Hamad described the discovery of the pills as 'the most despicable form of genocide'. Khalil Mazen Abu Nada, a Palestinian doctor in Gaza, also posted about the drug on Facebook, describing it as a 'means to obliterate our societal awareness'. The Gaza government media office said it held Israel 'fully responsible for this heinous crime of spreading addiction and destroying the Palestinian social fabric from within'. Israel kills 25 Palestinians seeking aid as hospitals warn of infant mortalities Read More » The office also decried the Israeli military's 'exploitation of the blockade to smuggle these substances as 'aid and assistance'', describing the Israeli and American-operated aid centres as 'death traps'. The Gaza Humanitarian Foundation (GHF), the controversial US-Israeli organisation operating aid points in Gaza, has been widely condemned by human rights organisations for its lack of transparency and accountability. On Wednesday, 15 human rights and legal groups called for the suspension of GHF for its role in undermining international humanitarian organisations and fostering the 'forced displacement' of Palestinians in Gaza, amounting to what could be complicity in 'crimes under international law, including war crimes, crimes against humanity, or genocide'. Gaza's health authorities have reported that at least 516 Palestinians have been killed by Israeli forces near aid sites in the past month of GHF's operations. On Friday, Haaretz reported Israeli soldiers admitting to directly shooting and killing unarmed Palestinians at GHF-operated aid collection sites. Middle East Eye has asked the GHF for comment.


Al Etihad
2 days ago
- Al Etihad
Chile observatory captures the universe with 3,200-megapixel camera
27 June 2025 18:09 SANTIAGO (Reuters) Chile's Vera C. Rubin Observatory, which boasts the world's largest digital camera, has begun displaying its first images of the cosmos, allowing astronomers to figure out how the solar system formed and even whether an asteroid poses a threat to on Pachon Hill in the northern region of Coquimbo, the 8.4-meter (27-1/2-foot) telescope has a 3,200-megapixel camera feeding a powerful data processing system."It's really going to change and challenge the way people work with their data," said William O'Mullane, a project manager focused on data at Vera observatory detected over 2,100 previously unseen asteroids in 10 hours of observations, focusing on a small area of the visible sky. Its ground-based and space-based peers discover in total some 20,000 asteroids a year.O'Mullane said the observatory would allow astronomers to collect huge amounts of data quickly and make unexpected finds."Rather than the usual couple of observations and writing an (academic) paper. No, I'll give you a million galaxies. I'll give you a million stars or a billion even, because we have them: 20 billion galaxy measurements," he center is named after American astronomer Vera C. Rubin, a pioneer in finding conclusive evidence of the existence of large amounts of invisible material known as dark night, Rubin will take some 1,000 images of the southern hemisphere sky, letting it cover the entire southern sky every three or four nights. The darkest skies above the arid Atacama Desert make Chile one of the best places worldwide for astronomical observation."The number of alerts the telescope will send every night is equivalent to the inboxes of 83,000 people. It's impossible for someone to look at that one by one," said astrophysicist Francisco Foster. "We're going to have to use artificial intelligence tools."